Riskpilot← Back to searchSign inGet full accessNYT SYN TORVEGADE ApS
APSActiveCVR 32670857Torvegade 10Retail sale of medical and orthopaedic goods · NACE 4774Est. 20107 employees
Revenue 2025
DKK 5,8M
+22% vs 2024
EBITDA margin
44.4%
+45% vs 2024
Equity ratio
68.9%
Financial strength
Net profit 2025
DKK 1,9M
+46% vs 2024
| Revenue | DKK 5,8M | +22% |
| EBITDA | DKK 2,6M | +45% |
| Net profit | DKK 1,9M | +46% |
| Total assets | DKK 3,5M | +27% |
| Equity | DKK 2,4M | +39% |
| Employees | 7 | — |
Legal name
NYT SYN TORVEGADE ApS
CVR number
32670857
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
1. januar 2010
Share capital
DKK 125.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Direktionen tegner selskabet vedrørende den daglige drift. Enkeltstående større dispositioner af økonomisk betydning kan kun indgås af alle direktionens medlemmer i forening.
Company purpose
Selskabets formål er at drive optikervirsomhed samt aktiviteter i tilknytning hertil.
Address
Torvegade 10
Phone
+4586414000
Email
torvegade@nytsyn.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.021 | 708 | 884 | 1.056 | 2.191 | 2.793 | 3.164 | 4.604 | 4.906 | 4.876 | 5.652 | 4.235 | 4.759 | 5.826 |
| Staff expenses | -600 | -586 | -658 | -718 | -718 | -1.775 | -1.885 | -2.624 | -2.668 | -2.811 | -3.032 | -2.869 | -2.970 | -3.239 |
| EBITDA | 244 | -37 | 70 | 286 | 909 | 1.018 | 1.185 | 1.980 | 2.239 | 2.064 | 2.620 | 1.366 | 1.789 | 2.587 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -34 | -51 | -93 | -185 | -190 | -225 | -184 | -177 | -58 | -63 |
| EBIT | 244 | -37 | 70 | 286 | 875 | 967 | 1.092 | 1.795 | 2.049 | 1.840 | 2.437 | 1.189 | 1.731 | 2.524 |
| Net financials | -158 | -148 | -119 | -109 | -98 | -162 | -166 | -141 | -240 | -220 | -257 | -150 | -77 | -112 |
| Profit before tax | 85 | -185 | -49 | 177 | 777 | 806 | 926 | 1.654 | 1.809 | 1.620 | 2.180 | 1.039 | 1.654 | 2.413 |
| Tax | 21 | -25 | -0 | 40 | 171 | 177 | 205 | 366 | 402 | 360 | 483 | 232 | 366 | 533 |
| Net profit | 64 | -160 | -49 | 137 | 606 | 628 | 721 | 1.288 | 1.407 | 1.260 | 1.697 | 807 | 1.289 | 1.879 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 998 | 860 | 1.255 | 1.176 | 1.295 | 1.392 | 1.875 | 2.977 | 3.849 | 2.741 | 3.230 | 2.394 | 2.761 | 3.494 |
| Equity | — | 187 | 138 | 275 | 731 | 559 | 879 | 1.467 | 1.675 | 1.535 | 2.031 | 1.238 | 1.727 | 2.406 |
| Long-term debt | 792 | 0 | 0 | 0 | 0 | 0 | 0 | 45 | 126 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.044 | 1.100 | 1.117 | 898 | 565 | 807 | 940 | 1.412 | 1.984 | 1.185 | 1.172 | 1.152 | 1.031 | 1.074 |
| Total debt | 1.837 | 1.100 | 1.117 | 900 | 565 | 807 | 940 | 1.458 | 2.111 | 1.185 | 1.172 | 1.152 | 1.031 | 1.074 |
EBITDA margin
44.4%
This company
15.8%
Market median
+181% vs market
20122025
Equity ratio
68.9%
This company
38.2%
Market median
+80% vs market
20122025
Return on equity
78.1%
This company
18.4%
Market median
+324% vs market
20122025
Net profit margin
32.3%
This company
8.1%
Market median
+299% vs market
20122025
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20122025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
SG Management | Management | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Guldager Holding Randers ApS | Company | 50.0% | 50.0% | 2016 |
MUNK & HVASS HOLDING ApS | Company | 50.0% | 50.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Guldager Holding Randers ApS
NYT SYN TORVEGADE ApS Board members of NYT SYN TORVEGADE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annie Hvass Munk | Chief Executive Officer | 0 companies |
| Steen Guldager | Management | 0 companies |
| Jesper Munk | Chairman | 0 companies |